PVG.L Regulatory News (PVG)

9 Jun 2006 13:58

Ark Therapeutics Group PLC09 June 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF LISTED COMPANY Ark Therapeutics Group plc 2) NAME OF SHAREHOLDER HAVING A MAJOR INTEREST J O Hambro Capital Management Limited 3) Please state whether notification indicates that it is regarding the holding of the shareholder named in 2 above; in respect of a non-beneficial interest; or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 2 above as investment manager for FF&P Small Cap UK Equity Fund (a sub-fund of FF&P Global Equities Umbrella Fund) in respect of a holding of 671,428 ordinary shares and also includes a non-material interest in 4,413,866 ordinary shares (see 14 below) 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them. The Bank of New York (Nominees) Limited 5) Number of shares/amount of stock acquired. 1,000,000 6) Percentage of issued Class (any treasury shares held by the listed company should not be taken into account when calculating percentage) 0.63% 7) Number of shares/amount of stock disposed N/A 8) Percentage of issued Class (any treasury shares held by the listed company should not be taken into account when calculating percentage) N/A 9) Class of security Ordinary shares 10) Date of transaction 7 June 2006 11) Date listed company informed 8 June 2006 12) Total holding following this notification 5,085,294 13) Total percentage holding of issued class following this notification (any treasury shares held by the listed company should not be taken into account when calculating percentage) 3.19% 14) Any additional information Includes a non-material interest for the purposes of section 199 2A CompaniesAct 1985 of 4,413,866 ordinary shares in which a Limited Liability Partnershipowned by J O Hambro Capital Management Group Limited is interested as investmentmanager of undertakings for collective investments in transferable securities(UCITS) 15) Name of contact and telephone number for queries Martyn Williams - +44 (0)207 388 7722 16) Name and signature of duly authorised officer of the listed company responsible for making this notification Martyn Williams - Chief Financial Officer Date of Notification ......9 June 2006 This information is provided by RNS The company news service from the London Stock Exchange